Form 8-K - Current report:
SEC Accession No. 0001668397-25-000085
Filing Date
2025-07-21
Accepted
2025-07-21 16:15:18
Documents
15
Period of Report
2025-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K medp-20250717.htm   iXBRL 8-K 28454
2 EX-10.1 medp-20250721xexx101.htm EX-10.1 142958
3 EX-99.1 medp-2025721exx991.htm EX-99.1 175714
7 medpace-logoxonxwhitea.jpg GRAPHIC 10438
  Complete submission text file 0001668397-25-000085.txt   522703

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT medp-20250717.xsd EX-101.SCH 1770
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT medp-20250717_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT medp-20250717_pre.xml EX-101.PRE 12500
17 EXTRACTED XBRL INSTANCE DOCUMENT medp-20250717_htm.xml XML 2702
Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address 5375 MEDPACE WAY CINCINNATI OH 45227 (513) 579-9911
Medpace Holdings, Inc. (Filer) CIK: 0001668397 (see all company filings)

EIN.: 320434904 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37856 | Film No.: 251137446
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)